These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 2424118
1. Vitamin K antagonism of coumarin intoxication in the rat. Wallin R, Patrick SD, Ballard JO. Thromb Haemost; 1986 Apr 30; 55(2):235-9. PubMed ID: 2424118 [Abstract] [Full Text] [Related]
2. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin. Wallin R, Martin LF. J Clin Invest; 1985 Nov 30; 76(5):1879-84. PubMed ID: 3932474 [Abstract] [Full Text] [Related]
3. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver. Hildebrandt EF, Suttie JW. Biochemistry; 1982 May 11; 21(10):2406-11. PubMed ID: 6807339 [Abstract] [Full Text] [Related]
4. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat. de Boer-van den Berg MA, Thijssen HH, Vermeer C. Biochim Biophys Acta; 1986 Oct 29; 884(1):150-7. PubMed ID: 3490277 [Abstract] [Full Text] [Related]
5. Recent findings in understanding the biological function of vitamin K. Uotila L, Suttie JW. Med Biol; 1982 Feb 29; 60(1):16-24. PubMed ID: 6803084 [Abstract] [Full Text] [Related]
6. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat. Mosterd JJ, Thijssen HH. J Pharmacol Exp Ther; 1992 Mar 29; 260(3):1081-5. PubMed ID: 1545379 [Abstract] [Full Text] [Related]
8. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo. Wallin R, Martin LF. Biochem J; 1987 Jan 15; 241(2):389-96. PubMed ID: 3593198 [Abstract] [Full Text] [Related]
9. The long-term effects of the rodenticide, brodifacoum, on blood coagulation and vitamin K metabolism in rats. Mosterd JJ, Thijssen HH. Br J Pharmacol; 1991 Oct 15; 104(2):531-5. PubMed ID: 1797316 [Abstract] [Full Text] [Related]
10. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity. Thijssen HH, Baars LG, Vervoort-Peters HT. Br J Pharmacol; 1988 Nov 15; 95(3):675-82. PubMed ID: 3207986 [Abstract] [Full Text] [Related]
15. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats. Yamanaka Y, Yamano M, Yasunaga K, Shike T, Uchida K. Thromb Res; 1990 Jan 15; 57(2):205-14. PubMed ID: 2315885 [Abstract] [Full Text] [Related]
16. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats. MacNicoll AD. Biochim Biophys Acta; 1985 May 29; 840(1):13-20. PubMed ID: 3995080 [Abstract] [Full Text] [Related]
18. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase. Creedon KA, Suttie JW. Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564 [Abstract] [Full Text] [Related]
19. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction. Lee JJ, Principe LM, Fasco MJ. Biochemistry; 1985 Dec 03; 24(25):7063-70. PubMed ID: 4084561 [Abstract] [Full Text] [Related]
20. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase. Uitendaal MP, Thijssen HH, Drittij-Reijnders MJ, Hoeijmakers MJ. Biochem Biophys Res Commun; 1986 Jun 30; 137(3):1015-20. PubMed ID: 3729947 [Abstract] [Full Text] [Related] Page: [Next] [New Search]